The MyPeBS (My Personal Breast Screening) study aims to replace the generalised screening of breast cancer depending on age with personalised screenings based on the Mammorisk test, which predicts the 5-year risk of breast cancer.
Depending on this test, women will undergo mammograms at a younger age, as well as ultrasounds and/or MRIs depending on their risk.
The expected benefit is 30% less stage II breast cancers, and therefore around 30% less deaths. This test is intended to be generalised after 2025 for 125 million European women over 40 years old. It has received funding of 12.5 million Euros from the European Union.